San Antonio, TX
United States
University of Texas at San Antonio - Division of Hematology and Medical Oncology
CCUS; cluster; hub; techno-economic evaluation; CO2 value chain; biogenic CO2 ; EU ETS; business model; Europe; scenario;negative emissions
RET mutation, RET fusion, oncogenic fusion, pheochromocytoma, paraganglioma, tyrosine kinase inhibitor, GRB2, driver genetic events, selpercatinib, pralsetinib